Letters Polypharmacy and acute kidney injury

More evidence of nephrotoxicity with renin-angiotensin-aldosterone system blockers

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f661 (Published 19 February 2013) Cite this as: BMJ 2013;346:f661
  1. Jose Mario Franco de Oliveira, associate professor of medicine1
  1. 1Universidade Federal Fluminense, Niterói - RJ, 24220-008, Brazil
  1. jmariofranco{at}gmail.com

Lapi and colleagues provide more evidence that renin-angiotensin-aldosterone system (RAAS) blockers can be nephrotoxic in the long term in certain populations1 2—namely, older patients with chronic kidney disease, with or without diabetes.3

A few …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial